Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate

scientific article published on 5 June 2006

Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2006.04.069
P8608Fatcat IDrelease_y3lbaufei5e7rmqd7t3b4yiwjm
P698PubMed publication ID16814434
P5875ResearchGate publication ID6971193

P2093author name stringThierry Fontaine
Inge Holm
Sarah Bonnet
Stéphane Pêtres
Shirley Longacre
Sandrine Rosario
Charles Roth
P433issue33-34
P407language of work or nameEnglishQ1860
P921main subjectmalariaQ12156
Plasmodium falciparumQ311383
malaria vaccineQ6741353
P304page(s)5997-6008
P577publication date2006-06-05
P1433published inVaccineQ7907941
P1476titleSoluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate
P478volume24